Streetbeat News

Products Services

ITRI

Itron, Inc. (NASDAQ:ITRI) has completed a technology transfer to Sui Southern Gas Company Limited (SSGC) in Pakistan, enabling SSGC to localize manufacturing of the Gallus G4 residential gas meter. The collaboration between Itron and SSGC dates back over 30 years and has led to local production of parts and assembly of various models of domestic gas meters. The Gallus G4 meter can be equipped with communication technology for remote meter reading, potentially optimizing operations and reducing losses.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:59 pm

EOLS

Evolus, Inc. (NASDAQ:EOLS) has unveiled a new branding for its flagship product, Jeuveau, a neurotoxin dedicated exclusively for aesthetics. The rebranding aims to reflect the evolving consumer base and break away from the traditional tone of the neurotoxin market. Jeuveau has been the fastest-growing neurotoxin in the U.S. for two consecutive years and holds an estimated 11% of the U.S. cosmetic neurotoxin market.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:58 pm

CDXC

ChromaDex Corp. (NASDAQ:CDXC) has announced a partnership with iHerb, a leading online health and wellness retailer, to distribute its product Tru Niagen globally. This move is expected to accelerate Tru Niagen's global expansion as nearly 90% of iHerb's sales are generated outside of the United States. iHerb has a larger global audience than Vitacost, VitaminShoppe, and GNC combined, with 10 million active customers across more than 180 countries.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:55 pm

NEOG

Neogen Corporation (NEOG) has introduced over 100 new genetic tests through its Paw Print Genetics and Canine HealthCheck solutions. Paw Print Genetics has introduced 49 new tests, increasing its full testing portfolio to nearly 350 breed-specific tests. Canine HealthCheck has introduced 69 new tests, increasing its full testing portfolio to over 325 diseases and traits. The tests provide insights into color and trait genotypes and identify genetic mutations associated with disease.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 12:51 pm

VIRX

Viracta Therapeutics, Inc. (NASDAQ:VIRX) has announced the publication of clinical data from a Phase 1b/2 study of Nana-val in 55 patients with R/R EBV+ lymphoma. The results showed complete responses and ongoing durable responses observed out to approximately 36 months across multiple EBV+ lymphoma subtypes. The all-oral Nana-val was well tolerated, with the most common adverse events being low-grade nausea, constipation, and reversible cytopenias. The data served as a catalyst for the advancement of Nana-val into the confirmatory NAVAL-1 trial.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:51 pm

NVAX

Novavax executive has stated that the demand for Covid vaccine in the U.S. market this fall will range from 80M-100M doses. The company has contracts and negotiated pricing in place for Covid shots with the U.S. CDC and other entities.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:50 pm

TBLT

ToughBuilt Industries, Inc. (NASDAQ:TBLT) has announced its expansion into the European Union through partnerships with French retailer La Platforme Du Batiment and Prolians. This move will provide access to ToughBuilt products to a potential 600,000+ customers across both retail groups in France and Spain. The expansion includes representation in more than 290 storefronts across the two countries.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:49 pm

VRAR

The Glimpse Group, Inc. (NASDAQ:VRAR) has announced two follow-on contracts with major organizations. One contract, estimated in the low six figures, is for a logistics-focused VR Simulation and software license with a major NYC hospital. The other contract, estimated in the high five figures, is for two webAR experiences with one of the world's largest consumer packaged goods companies. These contracts demonstrate the power of the Glimpse ecosystem and how immersive technologies are being utilized in real-world enterprise scenarios.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:39 pm

PBYI

Puma Biotechnology has received FDA clearance for its Investigational New Drug (IND) application for Alisertib in small cell lung cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 12:38 pm

MYNA

Mynaric (NASDAQ:MYNA) announced the results of its annual general assembly, with Bulent Altan and Margaret Abernathy joining the Supervisory Board. Bulent Altan was elected as Chairman. Mustafa Veziroglu will serve as the sole CEO, leading the company's operations and strategy to produce laser communications terminals at scale. The company has the largest backlog of terminals in its history and plans to start delivering products at scale from 2023.

Portfolio Pulse from Happy Mohamed

August 08, 2023 | 12:37 pm